Background: Robot-assisted partial nephrectomy (RAPN) is increasingly being employed in the management of renal cell carcinoma (RCC) and it is expanding in the field of complex renal tumors. The aim of this systematic review was to consolidate and assess the results of RAPN when dealing with entirely central hilar masses and to examine the various methods used to address the surgical difficulties associated with them.Methods: A thorough literature search in September 2023 across various databases focused on RAPN for renal hilar masses, adhering to PRISMA guidelines. The primary goal was to evaluate RAPN’s surgical and functional outcomes, with a secondary aim of examining different surgical techniques. Out of 1250 records, 13 full-text manuscripts were reviewed.Results: Evidence is growing in favor of RAPN for renal hilar masses. Despite a predominance of retrospective studies and a lack of long-term data, RAPN shows positive surgical outcomes and preserves renal function without compromising cancer treatment effectiveness. Innovative suturing and clamping methods are emerging in surgical management.Conclusions: RAPN is a promising technique for managing renal hilar masses in RCC, offering effective surgical outcomes and renal function preservation. The study highlights the need for more long-term data and prospective studies to further validate these findings.
背景：机器人辅助肾部分切除术（RAPN）在肾细胞癌（RCC）治疗中的应用日益广泛，并逐步扩展至复杂肾肿瘤领域。本系统综述旨在整合并评估RAPN在处理完全位于肾门中央的肿瘤时的疗效，同时探讨针对相关手术难点的不同技术方法。 方法：遵循PRISMA指南，于2023年9月对多个数据库进行系统性文献检索，聚焦于RAPN治疗肾门肿瘤的相关研究。主要目标是评估RAPN的手术效果与功能预后，次要目标为分析不同手术技术。在1250篇文献记录中，最终对13篇全文文献进行了深入评析。 结果：现有证据表明RAPN在肾门肿瘤治疗中具有应用前景。尽管目前研究以回顾性分析为主且缺乏长期数据，但RAPN显示出良好的手术效果，能在保证肿瘤治疗效果的同时有效保护肾功能。手术实践中正在涌现创新的缝合与阻断技术。 结论：RAPN是治疗肾细胞癌肾门肿瘤的可行技术，既能实现有效的手术治疗，又能保护肾功能。本研究强调需要更多长期数据和前瞻性研究来进一步验证这些发现。
肿瘤(癌症)患者之家